ALVOTECH
Ownership & governance
Executives 5Directors 6Avg age 57Avg tenure 4y
LG
Lisa Graver
Chief Executive Officer
Age 55Since 2026-02-28
+10
Executives5
LG
Lisa Graver
Chief Executive Officer
Age 55Since 2026-02-28
LJ
Linda Jonsdottir
Director of Finance/CFO
Age 48Since 2025-07-09
GZ
Giedrius Zunda
Chief Tech/Sci/R&D Officer
—Since 2022-12-31
JM
Joseph McClellan
Chief Operating Officer
Age 52Since 2025-11-11
BS
Benedikt Stefansson
Investor Relations Contact
—Since 2022-03-01
Board of directors6
VW
Vilhelm Wessman
Chairman
Age 56Since 2018-12-31
RD
Richard Davies
Director/Board Member
Age 64Since 2018-12-31
TE
Tomas Ekman
Director/Board Member
Age 58Since 2018-12-31
AM
Ann Merchant
Director/Board Member
Age 61Since 2022-06-15
ÁH
Árni Harðarson
Director/Board Member
Age 59Since 2022-06-15
HP
Hjörleifur Pálsson
Director/Board Member
Age 62Since 2024-06-06
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Celtic Holdings SCA | 34.43 % | 107,450,988 |
| Aztiq Pharma Partners SARL | 33.28 % | 103,849,420 |
| ALVOTECH | 1.212 % | 3,780,922 |
| Vanguard Capital Management LLC | 1.093 % | 3,410,447 |
| Bracebridge Capital LLC | 0.867 % | 2,705,304 |
Catalog · 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 6.8Range 4–9Analysts 5
4Mean 6.89
- Strong buy 2
- Buy 4
- Hold 1
Broker actions23
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Barclays | Upgrade | Overweight | 8 | 2026-09-16 |
| B of A Securities | Initiated | Buy | 7 | 2026-08-24 |
| Evercore ISI Group | Initiated | Outperform | — | 2026-08-14 |
| UBS | Maintained | Buy | 6 | 2026-03-24 |
| Barclays | Maintained | Underweight | 4 | 2026-03-24 |
| Barclays | Initiated | Underweight | 5 | 2025-12-09 |
| UBS | Maintained | Buy | 10 | 2025-11-18 |
| Deutsche Bank | Downgrade | Hold | 8 | 2025-11-04 |
| Morgan Stanley | Upgrade | Overweight | 14 | 2025-10-14 |
| Deutsche Bank | Upgrade | Buy | 14 | 2025-09-23 |
| UBS | Maintained | Buy | 14 | 2025-07-18 |
| UBS | Initiated | Buy | 18 | 2025-02-14 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.